XML 17 R6.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common stock and additional paid-in capital
Retained earnings
Accumulated other comprehensive income (loss)
Beginning balance (in shares) at Dec. 31, 2017   10,829,918    
Beginning balance at Dec. 31, 2017 $ 181,321 $ 61,855 $ 121,144 $ (1,678)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 5,506   5,506  
Net unrealized loss on securities available for sale, net of tax (3,309)     (3,309)
Net unrealized loss on cash flow hedging derivative instruments, net of tax 384     384
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax (8)     (8)
Comprehensive income 2,573   5,506 (2,933)
Cash dividends declared (2,607)   (2,607)  
Equity compensation expense 95 $ 95    
Payment to repurchase of common stock (in shares)   (5,725)    
Payment to repurchase common stock (167)   (167)  
Issuance of restricted stock (in shares)   16,795    
Proceeds from sale of common stock (in shares)   5,574    
Proceeds from sale of common stock $ 157 $ 157    
Ending balance (in shares) at Mar. 31, 2018 10,846,562 10,846,562    
Ending balance at Mar. 31, 2018 $ 181,372 $ 62,107 123,876 (4,611)
Beginning balance (in shares) at Dec. 31, 2018 10,862,651 10,862,651    
Beginning balance at Dec. 31, 2018 $ 191,542 $ 62,855 132,460 (3,773)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 6,156   6,156  
Net unrealized loss on securities available for sale, net of tax 3,512     3,512
Net unrealized loss on cash flow hedging derivative instruments, net of tax (465)     (465)
Net unrealized gain on securities transferred from available for sale to held to maturity, net of tax 3     3
Comprehensive income 9,206   6,156 3,050
Cash dividends declared (3,156)   (3,156)  
Equity compensation expense 123 $ 123    
Payment to repurchase of common stock (in shares)   (3,804)    
Payment to repurchase common stock (96)   (96)  
Issuance of restricted stock (in shares)   19,087    
Proceeds from sale of common stock (in shares)   6,447    
Proceeds from sale of common stock $ 168 $ 168    
Ending balance (in shares) at Mar. 31, 2019 10,884,381 10,884,381    
Ending balance at Mar. 31, 2019 $ 197,787 $ 63,146 $ 135,364 $ (723)